# Mission Connect Mild Traumatic Brain Injury (TBI) Integrated Clinical Protocol

> **NCT01013870** · PHASE2 · TERMINATED · sponsor: **Baylor College of Medicine** · enrollment: 52 (actual)

## Conditions studied

- Traumatic Brain Injury
- Post-traumatic Stress Disorder

## Interventions

- **DRUG:** Atorvastatin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01013870
- **Lead sponsor:** Baylor College of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-02
- **Primary completion:** 2015-03
- **Final completion:** 2015-06
- **Target enrollment:** 52 (ACTUAL)
- **Why stopped:** inability to recruit adequate numbers of subjects
- **Last updated:** 2017-01-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01013870

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01013870, "Mission Connect Mild Traumatic Brain Injury (TBI) Integrated Clinical Protocol". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01013870. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*